Brand name: ARIMIDEX
ສ່ວນປະກອບ:
ໃນ 1 ເມັດປະກອບດ້ວຍ:
Anastrozole ……………………………..1mg
ຂໍ້ບົ່ງໃຊ້:
- It is suitable for advanced breast cancer in postmenopausal women who cannot be controlled by tamoxifen and other anti-estrogen therapies.
- Adjuvant treatment of estrogen-positive early breast cancer in postmenopausal women.
- For patients with negative estrogen receptors and a positive clinical response to tamoxifen, this product may be considered.
ວິທີໃຊ້:
- Take 1 tablet (1mg) orally once daily. In patients with mild hepatic impairment or mild to moderate renal impairment, dose adjustment is generally not required
ຂໍ້ຫ້າມໃຊ້:
This product is contraindicated in the following situations:
- Premenopausal women
- Pregnant or lactating women
- Patients with severe renal damage (creatinine clearance <20ml/min)
- Patients with moderate to severe liver damage
- Known Patients who are highly sensitive to anastrozole and its preparation excipients
ຄຳເຕືອນ:
- There is no data on the safety of anastrozole tablets in patients with moderate to severe hepatic impairment and severe renal impairment.
- When doubts arise about hormone levels, amenorrhea should be considered to be due to a disruption in hormonal balance.
- This product has no significant impact on patients’ ability to drive and operate machinery.
- However, it has been reported that some patients have symptoms of fatigue and depression.
- When the above symptoms persist, patients should pay special attention when driving and operating machinery.
ຜົນຂ້າງຄຽງ:
- Side effects of this product mainly include skin flushing, vaginal dryness, excessive hair oil secretion, gastrointestinal disorders (anorexia, nausea, vomiting and diarrhea), fatigue, depression, headache or rash, etc. Side effects are usually mild or moderate and easily tolerated by patients.
- Uterine bleeding with this product is occasionally reported, mainly in the first few weeks after patients switch from existing hormone therapy to this product. If bleeding continues, further evaluation is required.
- Changes in liver function (such as increased transpeptidase and alkaline phosphatase) have been reported in patients with advanced breast cancer treated with this product, but many of these patients already have liver metastasis or bone metastasis. Research into the causes of these changes has not yet been conducted. Clinical observation shows that this product can slightly increase plasma total cholesterol levels.
ຮູບແບບ: ຢາເມັດສີຂາວ.
ວັນທີໝົດອາຍຸ: 24 ເດືອນ ຫຼັງຈາກວັນທີຜະລິດ.
ຂະໜາດບັນຈຸ: 1 mg/tablets, 10 tablets/blister, 10 blisters/ box.
ການເກັບຮັກສາ:
- ເກັບຮັກສາໄວ້ໃນກັບກ່ອງ ບັນຈຸເດີມ, ບໍ່ໃຫ້ຖືກແສງ ເກັບໄວ້ໃນຫ້ອງທີ່ມີ ອຸນຫະພູມ ລະຫວ່າງ 20℃-25℃.
- ເກັບໄວ້ໃຫ້ຫ່າງໄກຈາກມືເດັກນ້ອຍ.
ຂໍ້ຄວາມປະຕິເສດຄວາມຮັບຜິດຊອບ
ຂໍ້ມູນເທິງເວັບໄຊນີ້ກ່ຽວກັບຢາຂອງເຮົາແມ່ນມີຈຸດປະສົງເພື່ອການສຶກສາທົ່ວໄປເເທົ່ານັ້ນ ແລະ ບໍ່ຄວນຖືເປັນການແນະນຳທາງການແພດ, ການວິນິດໄສ ຫຼື ການປິ່ນປົວຈາກແພດຜູ້ຊ່ຽວຊານ. ຢ່າເບິ່ງຂ້າມຕໍ່ຄຳແນະນຳຂອງແພດຜູ້ຊ່ຽວຊານ ຫຼື ຊັກຊ້າໃນການເຂົ້າຮັບການຮັກສາ ຍ້ອນສິ່ງທີ່ໄດ້ອ່ານຈາກເວັບໄຊນີ້.
ເພື່ອຄວາມປອດໄພຂອງທ່ານ:
ຫ້າມວິນິດໄສຕົນເອງ ຫຼື ຮັກສາອາການໃດໆ ໂດຍອາໄສຂໍ້ມູນເທິງເວັບໄຊນີ້ພຽງຢ່າງດຽວ. ຖ້າຫາກທ່ານມີຄຳຖາມ ຫຼື ຂໍ້ກັງວົນກ່ຽວກັບຢາ ກະລຸນາ
